151 related articles for article (PubMed ID: 37762056)
1. Antiproliferative and Antimetastatic Properties of 16-Azidomethyl Substituted 3-
Senobar Tahaei SA; Kulmány Á; Minorics R; Kiss A; Szabó Z; Germán P; Szebeni GJ; Gémes N; Mernyák E; Zupkó I
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762056
[TBL] [Abstract][Full Text] [Related]
2. Antiproliferative and antimetastatic properties of 3-benzyloxy-16-hydroxymethylene-estradiol analogs against breast cancer cell lines.
Sinka I; Kiss A; Mernyák E; Wölfling J; Schneider G; Ocsovszki I; Kuo CY; Wang HC; Zupkó I
Eur J Pharm Sci; 2018 Oct; 123():362-370. PubMed ID: 30010030
[TBL] [Abstract][Full Text] [Related]
3. Antiproliferative and antimetastatic characterization of an exo-heterocyclic androstane derivative against human breast cancer cell lines.
Kulmány ÁE; Frank É; Kovács D; Kirisits K; Krupitza G; Neuperger P; Alföldi R; Puskás LG; Szebeni GJ; Zupkó I
Biomed Pharmacother; 2021 Aug; 140():111728. PubMed ID: 34020244
[TBL] [Abstract][Full Text] [Related]
4. A click approach to novel D-ring-substituted 16α-triazolylestrone derivatives and characterization of their antiproliferative properties.
Molnár J; Frank É; Minorics R; Kádár Z; Ocsovszki I; Schönecker B; Wölfling J; Zupkó I
PLoS One; 2015; 10(2):e0118104. PubMed ID: 25692552
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of 2- and 17-substituted estrone analogs and their antiproliferative structure-activity relationships compared to 2-methoxyestradiol.
Shah JH; Agoston GE; Suwandi L; Hunsucker K; Pribluda V; Zhan XH; Swartz GM; LaVallee TM; Treston AM
Bioorg Med Chem; 2009 Oct; 17(20):7344-52. PubMed ID: 19762246
[TBL] [Abstract][Full Text] [Related]
6. Investigation of the Antineoplastic Effects of 2-(4-Chlorophenyl)-13α-Estrone Sulfamate against the HPV16-Positive Human Invasive Cervical Carcinoma Cell Line SiHa.
Ali H; Traj P; Szebeni GJ; Gémes N; Resch V; Paragi G; Mernyák E; Minorics R; Zupkó I
Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047597
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of estrone and estrone-3-O-sulfamate derivatives on mitotic. Arrest, apoptosis, and microtubule assembly in human breast cancer cells.
MacCarthy-Morrogh L; Townsend PA; Purohit A; Hejaz HAM ; Potter BVL ; Reed MJ; Packham G
Cancer Res; 2000 Oct; 60(19):5441-50. PubMed ID: 11034086
[TBL] [Abstract][Full Text] [Related]
8. 2-Methoxymethylestradiol: a new 2-methoxy estrogen analog that exhibits antiproliferative activity and alters tubulin dynamics.
Brueggemeier RW; Bhat AS; Lovely CJ; Coughenour HD; Joomprabutra S; Weitzel DH; Vandre DD; Yusuf F; Burak WE
J Steroid Biochem Mol Biol; 2001 Aug; 78(2):145-56. PubMed ID: 11566439
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of antiproliferative action of a new d-secoestrone-triazole derivative in cervical cancer cells and its effect on cancer cell motility.
Bózsity N; Minorics R; Szabó J; Mernyák E; Schneider G; Wölfling J; Wang HC; Wu CC; Ocsovszki I; Zupkó I
J Steroid Biochem Mol Biol; 2017 Jan; 165(Pt B):247-257. PubMed ID: 27363663
[TBL] [Abstract][Full Text] [Related]
10. Selective antiproliferative effect of C-2 halogenated 13α-estrones on cells expressing Organic anion-transporting polypeptide 2B1 (OATP2B1).
Laczkó-Rigó R; Bakos É; Jójárt R; Tömböly C; Mernyák E; Özvegy-Laczka C
Toxicol Appl Pharmacol; 2021 Oct; 429():115704. PubMed ID: 34474082
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of trans-16-triazolyl-13α-methyl-17-estradiol diastereomers and the effects of structural modifications on their in vitro antiproliferative activities.
Mernyák E; Kovács I; Minorics R; Sere P; Czégány D; Sinka I; Wölfling J; Schneider G; Újfaludi Z; Boros I; Ocsovszki I; Varga M; Zupkó I
J Steroid Biochem Mol Biol; 2015 Jun; 150():123-34. PubMed ID: 25845933
[TBL] [Abstract][Full Text] [Related]
12. Antiproliferative Properties of Newly Synthesized 19-Nortestosterone Analogs Without Substantial Androgenic Activity.
Gyovai A; Minorics R; Kiss A; Mernyák E; Schneider G; Szekeres A; Kerekes E; Ocsovszki I; Zupkó I
Front Pharmacol; 2018; 9():825. PubMed ID: 30100876
[TBL] [Abstract][Full Text] [Related]
13. Estradiol and estrone C-16 derivatives as inhibitors of type 1 17beta-hydroxysteroid dehydrogenase: blocking of ER+ breast cancer cell proliferation induced by estrone.
Laplante Y; Cadot C; Fournier MA; Poirier D
Bioorg Med Chem; 2008 Feb; 16(4):1849-60. PubMed ID: 18035543
[TBL] [Abstract][Full Text] [Related]
14. Biological evaluation of antiproliferative and anti-invasive properties of an androstadiene derivative on human cervical cancer cell lines.
Kulmány ÁE; Frank É; Papp D; Szekeres A; Szebeni GJ; Zupkó I
J Steroid Biochem Mol Biol; 2021 Nov; 214():105990. PubMed ID: 34478830
[TBL] [Abstract][Full Text] [Related]
15. Synthetic Spirocyclohexadienones as New Anti-Migratory Compounds in Triple- Negative Breast Cancer Cell Migration.
Altei WF; Pachane BC; Martins LJ; Gomes RC; Santos RN; Fernandes DC; Selistre-de-Araújo HS; Coelho F; Andricopulo AD
Anticancer Agents Med Chem; 2021; 21(14):1901-1910. PubMed ID: 33292143
[TBL] [Abstract][Full Text] [Related]
16. Investigation of natural phenanthrenes and the antiproliferative potential of juncusol in cervical cancer cell lines.
Kuo CY; Schelz Z; Tóth B; Vasas A; Ocsovszki I; Chang FR; Hohmann J; Zupkó I; Wang HC
Phytomedicine; 2019 May; 58():152770. PubMed ID: 31005716
[TBL] [Abstract][Full Text] [Related]
17. Investigation of Anticancer Properties of Monoterpene-Aminopyrimidine Hybrids on A2780 Ovarian Cancer Cells.
Nagy V; Mounir R; Szebeni GJ; Szakonyi Z; Gémes N; Minorics R; Germán P; Zupkó I
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445759
[TBL] [Abstract][Full Text] [Related]
18. Antiproliferative effect of normal and 13-epi-D-homoestrone and their 3-methyl ethers on human reproductive cancer cell lines.
Minorics R; Bózsity N; Wölfling J; Mernyák E; Schneider G; Márki A; Falkay G; Ocsovszki I; Zupkó I
J Steroid Biochem Mol Biol; 2012 Oct; 132(1-2):168-75. PubMed ID: 22609630
[TBL] [Abstract][Full Text] [Related]
19. Development of potent non-estrogenic estrone sulfatase inhibitors.
Li PK; Chu GH; Guo JP; Peters A; Selcer KW
Steroids; 1998; 63(7-8):425-32. PubMed ID: 9654650
[TBL] [Abstract][Full Text] [Related]
20. Bioassays for estrogenic activity: development and validation of estrogen receptor (ERalpha/ERbeta) and breast cancer proliferation bioassays to measure serum estrogenic activity in clinical studies.
Li J; Lee L; Gong Y; Shen P; Wong SP; Wise SD; Yong EL
Assay Drug Dev Technol; 2009 Feb; 7(1):80-9. PubMed ID: 19382890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
